ABEONA THERAPEUTICS INC. (ticker: ABEO) is an NASDAQ-listed pharma company. DredgeCap's structured extraction of ABEO's SEC filings surfaces 4 active risk signals, including 2 late-filing signals, 1 auditor-change signal, and 1 delisting/deregistration signal. ABEO reported $8.72M in revenue and -$17.07M for the period ending 2026-03-31, with operating cash flow of -$19.80M. Cash and equivalents stood at $61.37M (up 285.1% year-over-year). Total assets of $198.49M exceed total liabilities of $53.55M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
ABEO Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for ABEONA THERAPEUTICS INC. (ABEO) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.